Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity

This top executive at Harmony Biosciences previous sold all of his direct shares in the company in early January 2026. But towards the end of the month, some options and restricted stock units vested, and everything changed. Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (HRMY 0.92%), executed an open-market sale of 3,746 shares on Jan. 26, 2026, totaling approximately 139,171,accordingtoaSECForm4filing.TransactionsummaryMetricValueSharessold(direct)3,746Transactionvalue139,171, according to a SEC Form 4 filing.Transaction summaryMetricValueShares sold (direct)3,746Transaction value139,171P ...